Maria Malin

Maria Malin serves as the FP&A Director at Abzena, where she plays a pivotal role in shaping the financial landscape of the company within the rapidly evolving biotech sector. With a robust background in biologics manufacturing and finance, Maria is passionate about delivering value not only to patients but also to stakeholders across the organization. Her current responsibilities include acting as a trusted advisor to Abzena's CFO, CEO, and senior leadership team, ensuring that financial and business decisions are grounded in comprehensive analysis and strategic foresight.

In her role, Maria leads the development and implementation of financial planning and reporting processes, which are crucial for navigating the complexities of contract development and manufacturing. She coordinates the annual planning cycles, quarterly forecasts, and monthly outlooks, ensuring that the organization remains agile and responsive to market dynamics. Maria is particularly adept at tracking key investments and performance metrics, producing high-quality insights that drive informed decision-making. Her expertise in financial modeling and analysis, combined with her proficiency in Microsoft Excel, allows her to distill complex data into actionable strategies that enhance operational efficiency and profitability.

Moreover, Maria's skills extend beyond finance; her background in project management and policy analysis equips her to contribute to cross-functional initiatives that align financial goals with broader business objectives. Fluent in Spanish and experienced in international relations, she brings a global perspective to her work, further enriching Abzena's commitment to innovation and excellence in the biotech industry. As the company continues to expand its integrated solutions from early discovery to mid-phase development, Maria's leadership in financial planning and analysis will be instrumental in driving sustainable growth and delivering on the promise of transformative therapies.